- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT03792893
Comparison of Pulse Wave and Blood Pressure Measurements Before, During and After Ergometry in Healthy Women
Comparison of Pulse Wave and Blood Pressure Parameters Before, During and After Exercise Ergometry in Healthy Female Subjects - a Randomized, Controlled, Single-blind Study
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
In a randomized single-blind study design the investigators explore how well blood pressure parameters calculated using a Pulse Transit Time-based method (device: SOMNOtouchTM RESP) match blood pressure parameters measured by a classic upper arm blood pressure cuff (BOSO-TM-2430 ) under standardized load conditions (ergometry).
In 30 healthy female subjects (age 18 - 40 years), cardiovascular parameters before, during and after a standardized load on a bicycle ergometer (half-lying position) are recorded with three different devices (BOSO-TM-2430 versus SOMNOtouchTM RESP versus GeTeMed Vitaguard 3100) and compared.
Primary outcome is the difference of the systolic blood pressure values between the devices BOSO-TM-2430 versus SOMNOtouchTM RESP during the three phases.
The BOSO-TM-2430 blood pressure cuff is applied randomized to the arm with the previously determined higher or lower systolic blood pressure mean difference. The subjects are blinded to the results of the measurements during ergometry.
After a pre-rest period of 12 minutes, the subjects are physically strained on the ergometer for 48 minutes (6 minutes loading phase followed by a 2-minute rest phase; 30 watts increase every 8 minutes up to a maximum load of 180 watts), followed by a 12-minute rest period. Measurements are taken every two minutes with the BOSO-TM-2430; data acquisition with the SOMNOtouchTM RESP and GeTeMed Vitaguard 3100 devices takes place continuously over a total duration of 72 minutes.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Baden Württemberg
-
Filderstadt, Baden Württemberg, Deutschland, 70794
- Arcim Institute
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Signed informed consent
- Healthy at the time of the examinations
- Inconspicuous anamnesis regarding cardiovascular diseases and bronchial asthma
- resting heart rate 50 to 100 beats per minute
- Normal blood pressure or appropriately treated and controlled hypertension (systolic blood pressure ≤ 140 mmHg and diastolic blood pressure ≤ 90 mmHg)
Exclusion Criteria:
- Acute or chronic (especially cardiovascular) diseases, including cardiac arrhythmia and vegetative regulatory disorders (recorded via anamnesis)
- Taking allopathic medication: digitalis, beta blockers, antiarrhythmics
- Bronchial asthma (recorded by anamnesis)
- Alcohol abuse
- Heart diseases NYHA class IV
- Blood pressure side difference ≥ 10mmHg
- Fever (> 37,5°C)
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Grundlegende Wissenschaft
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Higher Blood Pressure
BOSO-TM-2430 blood pressure cuff is applied to the upper arm with the previously determined higher systolic blood pressure.
Intervention: Ergometry H
|
After a pre-rest period of 12 minutes, the subjects are physically strained on the ergometer for 48 minutes (6 minutes loading phase followed by a 2-minute rest phase; 30 watts increase every 8 minutes up to a maximum load of 180 watts), followed by a 12-minute rest periodmaximum load of 180 watts), followed by a 15-minute post-rest period. BOSO-TM-2430 blood pressure cuff is applied to the upper arm with the previously determined higher systolic blood pressure (reference parameter). SOMNOtouchTM RESP and GeTeMed Vitaguard 3100 are accordingly applied to the arm with the previously determined lower systolic blood pressure. |
Experimental: Lower Blood Pressure
BOSO-TM-2430 blood pressure cuff is applied to the upper arm with the previously determined lower systolic blood pressure.
Intervention: Ergometry L
|
After a pre-rest period of 12 minutes, the subjects are physically strained on the ergometer for 48 minutes (6 minutes loading phase followed by a 2-minute rest phase; 30 watts increase every 8 minutes up to a maximum load of 180 watts), followed by a 12-minute rest periodmaximum load of 180 watts), followed by a 15-minute post-rest period. BOSO-TM-2430 blood pressure cuff is applied to the upper arm with the previously determined lower systolic blood pressure (reference parameter). SOMNOtouchTM RESP and GeTeMed Vitaguard 3100 are accordingly applied to the arm with the previously determined higher systolic blood pressure. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Difference of the systolic blood pressure
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Primary outcome is the difference of the systolic blood pressure values between the devices BOSO-TM-2430 versus SOMNOtouchTM RESP during the three phases
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Diastolic Blood Pressure (SOMNOtouchTM RESP)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Diastolic Blood Pressure (mm Hg) measured with the SOMNOtouchTM RESP device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Mean Arterial Blood Pressure (SOMNOtouchTM RESP)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Mean Arterial Blood Pressure (mm Hg) measured with the SOMNOtouchTM RESP device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Pulse Pressure (SOMNOtouchTM RESP)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Pulse Pressure (mm Hg) measured with the SOMNOtouchTM RESP device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Heartrate (SOMNOtouchTM RESP)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Heartrate (beats per minute, bpm) measured with the SOMNOtouchTM RESP device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Oxygen saturation (SpO2, SOMNOtouchTM RESP)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Oxygen saturation (% SpO2) measured with the SOMNOtouchTM RESP device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Pulse-Transit-Time (PTT, SOMNOtouchTM RESP)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Pulse-Transit-Time (PTT, ms) measured with the SOMNOtouchTM RESP device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Systolic Blood Pressure measured with the device BOSO-TM-2430
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Systolic Blood Pressure (mmHg) measured with the BOSO-TM-2430 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Diastolic Blood Pressure measured with the device BOSO-TM-2430
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Diastolic Blood Pressure (mmHg) measured with the BOSO-TM-2430 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Mean Arterial Blood Pressure measured with the device BOSO-TM-2430
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Mean Arterial Blood Pressure (mmHg) measured with the BOSO-TM-2430 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Pulse Pressure measured with the device BOSO-TM-2430
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Pulse Pressure (mmHg) measured with the BOSO-TM-2430 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Heartrate measured with the device BOSO-TM-2430
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Heartrate (beats per minute, bpm) measured with the BOSO-TM-2430 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Pulse Transit Time (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Pulse Transit Time (PTT, ms) measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Perfusion Index (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Perfusion Index (PI) measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Peak to Peak Time (PPT) (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Peak to Peak Time (PPT, ms) measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
SlopeInW1 (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
SlopeInW1 measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
SlopeInW2 (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
SlopeInW2 measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
SlopeInW3 (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
SlopeInW3 measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
SlopeInW4 (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
SlopeInW4 measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
StiffnessIndex (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
StiffnessIndex measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
ReflectionIndex (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
ReflectionIndex measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
TimeTX (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
TimeTX (ms) measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
TimeTY (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
TimeTY (ms) measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
QuotTYTX (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
QuotTYTX measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
AreaAX (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
AreaAX measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
AreaAY (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
AreaAY measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
QuotAYAX (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
QuotAYAX measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
AreaAV (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
AreaAV measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
AreaAW (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
AreaAW measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
QuotAWAV (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
QuotAWAV measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
QuotTVTW (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
QuotTVTW measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
TimeTV (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
TimeTV (ms) measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
TimeTW (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
TimeTW (ms) measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
MinT1 (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Minimum of the pulse wave measured with the GeTeMed Vitaguard 3100 device at the beginning of the first peak
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
MinT2 (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Minimum of the pulse wave measured with the GeTeMed Vitaguard 3100 device at the beginning of the second peak
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
MaxT1 (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Maximum of the pulse wave measured with the GeTeMed Vitaguard 3100 device at the maximum of the first peak
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
MaxT2 (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Maximum of the pulse wave measured with the GeTeMed Vitaguard 3100 device at the maximum of the second peak
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
QuotHRRespRate (GeTeMed Vitaguard 3100)
Zeitfenster: Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Quotient of heart and respiratory rates measured with the GeTeMed Vitaguard 3100 device
|
Physiological parameters are measured continuously (SOMNOtouchTM RESP) and every 2 minutes (BOSO-TM-2430) for a total duration of 72 minutes
|
Mitarbeiter und Ermittler
Mitarbeiter
Ermittler
- Studienleiter: Jan Vagedes, MD, ARCIM Institute, Im Haberschlai 7, 70794 Filderstadt, Germany
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- ERG_03
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Ergometry H
-
Allysta PharmaceuticalAbgeschlossen
-
Elizabeth K RhodusEmory University; National Institute on Aging (NIA)AbgeschlossenPsychische Störungen | Erkrankungen des Gehirns | Erkrankungen des zentralen Nervensystems | Erkrankungen des Nervensystems | Neurokognitive Störungen | Neurodegenerative Krankheiten | Demenz | Alzheimer Erkrankung | TauopathienVereinigte Staaten
-
Preceptis Medical, Inc.AbgeschlossenMittelohrentzündung | OhrinfektionVereinigte Staaten
-
Oryx GmbH & Co. KGAbgeschlossenGlioblastoma multiformeDeutschland
-
Samsung Medical CenterAbgeschlossenAlternKorea, Republik von
-
Idorsia Pharmaceuticals Ltd.AbgeschlossenAneurysmatische SubarachnoidalblutungVereinigte Staaten, Kanada
-
VA Office of Research and DevelopmentAbgeschlossenSchizophrenie | Schwere psychische ErkrankungVereinigte Staaten
-
University of ChicagoZurückgezogenErnährungsunsicherheit | Patientenzufriedenheit | Klinische Studie | Hunger | Betreuer | Gesundheitsbezogene Lebensqualität
-
Giancarlo ComiAbgeschlossenAlzheimer ErkrankungItalien
-
Tan Tock Seng HospitalARTICARES Pte LtdAbgeschlossen